Last updated on September 2018

A PHASE 2, RANDOMIZED, OPEN-LABEL TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A MULTIVALENT PNEUMOCOCCAL CONJUGATE VACCINE GIVEN WITH, OR SEPARATELY FROM, 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY INFANTS


Brief description of study

Active immunization to prevent disease caused by the Streptococcus pneumoniae serotypes in the vaccine.

Clinical Study Identifier: TX211860

Contact Investigators or Research Sites near you

Start Over